Skip to main content
. 2019 Feb 14;11:1525–1532. doi: 10.2147/CMAR.S191499

Figure 2.

Figure 2

Frequency of all grade toxicity, including hand-foot syndrome (A), hypocalcemia (B), rash (C), voice change (D), hypertension (E), nausea (F), elevated ALT (G), elevated AST (H), and vomiting (I), among sorafenib and lenvatinib.

Note: ****P<0.0001 indicates statistical significance.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.